Terms: = Lung cancer AND ENO2, HEL-S-279, NSE AND Treatment
249 results:
1. Application Value of CYFRA21-1 Combined with nse, CEA, and SCC-Ag in lung cancer.
Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
3. Determination of Tumor Marker Screening for lung cancer Using ROC Curves.
Dou X; Lu J; Yu Y; Yi Y; Zhou L
Dis Markers; 2024; 2024():4782618. PubMed ID: 38549716
[TBL] [Abstract] [Full Text] [Related]
4. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
[TBL] [Abstract] [Full Text] [Related]
5. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Trulson I; Klawonn F; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
[TBL] [Abstract] [Full Text] [Related]
6. Inhibitory effects of the nanoscale lysate derived from xenogenic dental pulp stem cells in lung cancer models.
He Y; Li R; She W; Ai Y; Li K; Kumeria T; Jiang Z; Shao Q; Zou C; Albashari AA; Duan X; Ye Q
J Nanobiotechnology; 2023 Dec; 21(1):488. PubMed ID: 38105218
[TBL] [Abstract] [Full Text] [Related]
7. Circulating lung cancer biomarkers: From translational research to clinical practice.
Qian X; Meng QH
Tumour Biol; 2024; 46(s1):S27-S33. PubMed ID: 37927289
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of tumor markers ProGRP, nse and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
Muley T; Herth FJ; Heussel CP; Kriegsmann M; Thomas M; Meister M; Schneider MA; Wehnl B; Mang A; Holdenrieder S
Tumour Biol; 2024; 46(s1):S219-S232. PubMed ID: 37840518
[TBL] [Abstract] [Full Text] [Related]
9. High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic cancer.
Qin L; Sun K; Shi L; Xu Y; Zhang R
Mediators Inflamm; 2023; 2023():4965223. PubMed ID: 37731842
[TBL] [Abstract] [Full Text] [Related]
10. Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen.
Zhang Y; Chao F; Lv L; Li M; Shen Z
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15365-15382. PubMed ID: 37639013
[TBL] [Abstract] [Full Text] [Related]
11. Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer.
van Delft FA; Schuurbiers MMF; Muller M; Burgers SA; van Rossum HH; IJzerman MJ; van den Heuvel MM; Koffijberg H
Tumour Biol; 2024; 46(s1):S269-S281. PubMed ID: 37545289
[TBL] [Abstract] [Full Text] [Related]
12. [Primary α-fetoprotein positive hepatoid adenocarcinoma of the lung: a case report].
Zhang K; Liu Q; Liu B; Lin D
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):700-707. PubMed ID: 37402661
[TBL] [Abstract] [Full Text] [Related]
13. Effect of I-125 Seed Implantation on lung cancer and Its Environmental Impact.
Lin C; Yang Z; Liu Q
Health Phys; 2023 Oct; 125(4):273-280. PubMed ID: 37347183
[TBL] [Abstract] [Full Text] [Related]
14. Peripheral Blood-Derived CircVPS35L as a Potential Diagnostic Biomarker for Non-Small Cell lung cancer.
Liang N; Zhang X; Zhang L; Jiang M; Bai H; Ding C; Cai Y; Zhou C; Han Y; Gong Z
Oncology; 2023; 101(8):527-536. PubMed ID: 37307805
[TBL] [Abstract] [Full Text] [Related]
15. Pre-analytical stability of the CEA, CYFRA 21.1, nse, CA125 and HE4 tumor markers.
Canki E; Schuurbiers MM; Linders TC; Korse CM; van den Heuvel MM; van Herwaarden AE; van Rossum HH
Tumour Biol; 2024; 46(s1):S15-S25. PubMed ID: 37302060
[TBL] [Abstract] [Full Text] [Related]
16. A nomogram to predict the cumulative risk for brain metastases in patients with limited-stage small cell lung cancer without prophylactic cranial irradiation.
Liu J; Wu D; Shen B; Chen M; Zhou X; Zhang P; Qiu G; Ji Y; Du X; Yang Y
Strahlenther Onkol; 2023 Aug; 199(8):727-738. PubMed ID: 37103529
[TBL] [Abstract] [Full Text] [Related]
17. Clinical role of serum tumor markers SCC, nse, CA 125, CA 19-9, and CYFRA 21-1 in patients with lung cancer.
Sun A
Lab Med; 2023 Nov; 54(6):638-645. PubMed ID: 37052517
[TBL] [Abstract] [Full Text] [Related]
18. Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1.
Liu C; Jin B; Liu Y; Juhua O; Bao B; Yang B; Liu X; Yu P; Luo Y; Wang S; Teng Z; Song N; Qu J; Zhao J; Chen Y; Qu X; Zhang L
Cancer Med; 2023 Apr; 12(8):9527-9540. PubMed ID: 37015898
[TBL] [Abstract] [Full Text] [Related]
19. The diagnostic value of Hsp90α in monitoring treatment responses in lung cancer.
Wang M; Jıang Z; Lıu R
Turk J Med Sci; 2022 Jun; 52(3):747-753. PubMed ID: 36326305
[TBL] [Abstract] [Full Text] [Related]
20. Desmoplastic Small Round Cell Tumor of the Head and Neck: A Clinicopathological, Immunohistochemical and Molecular Analysis of Three Cases with Literature Review.
Sun M; Shao M; Jiang X; Yin T; Wang Q; Zhao L; Liu J; Lao IW; Yu L; Wang J
Int J Surg Pathol; 2023 Aug; 31(5):742-750. PubMed ID: 36172631
[TBL] [Abstract] [Full Text] [Related]
[Next]
